The U.S. Centers for Disease Control and Prevention (CDC) set an Oct. 16 deadline for states to submit plans for distributing Covid-19 vaccines – even before it becomes clear when any will be available – according to a presentation to a panel of experts who make recommendations on U.S. vaccines.

The U.S. Centers for Disease Control and Prevention posted guidance on possible transmission of the new coronavirus through airborne particles in error and will be updating the CDC’s recommendations.

The U.S. Centers for Disease Control and Prevention warned that Covid-19 could spread through airborne particles that can remain suspended in the air and travel beyond six feet.

Moderna Inc. expects to produce 20 million doses of the company’s experimental coronavirus vaccine by the end of 2020.

Adult obesity is rising in the United States – with a greater impact on racial and ethnic minorities – a U.S. Centers for Disease Control (CDC) report showed, at a time when the health condition is seen causing heightened risk for severe Covid-19.

The U.S. Food and Drug Administration approved Athena Bioscience LLC’s Qdolo (tramadol hydrochloride) Oral Solution 5mg/1mL C-IV, an opioid agonist indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.

U.S. deaths from the coronavirus will reach 410,000 by the end of 2020 and deaths could soar to 3,000 per day in December, the University of Washington’s health institute forecast.

The Trump administration will send most of its newly purchased 150 million rapid Covid-19 tests to U.S. states for schools and critical services, a White House official said, as New York City pushed back reopening classrooms in a deal with union leaders.

The U.S. government will send an “overwhelming majority” of the rapid Covid-19 tests purchased from Abbott Laboratories to governors of states and territories to support school reopenings and other critical tasks, an administration official said at a press briefing.

A majority of U.S. states have rejected new Trump administration Covid-19 testing guidance in an extraordinary rebuke of the nation’s top agency for disease prevention, according to officials at state health agencies and public statements reviewed by Reuters.